| Heading: |
Givinostat |
| Question ID: |
1758690 |
| UIN: |
26401 |
| House: |
Commons |
| Date tabled: |
2025-01-24 |
| Asking Member ID: |
5329 |
| Asking Member display name: |
John Milne
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
John Milne
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if his Department will urge CEOs of relevant Trusts to provide (a) financial and (b) personnel support so that administration of givinostat can begin in weeks. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-02-03 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS independently, based on an assessment of their costs and benefits. T... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |